Comparative study on pharmacokinetics and toxicity of intravitreal and sub-Tenon injection of triamcinolone acetonide in ocular tissues

被引:3
|
作者
Arie, Yuko [1 ]
Miyai, Hiroko [1 ]
Suzuki, Ayako [1 ]
Okabe, Takeshi [1 ]
Takashima, Mitsuyo [1 ]
Takata, Mayumi [1 ]
Kurasawa, Takashi [1 ]
Ito, Masaki [1 ]
Arakawa, Reijiro [1 ]
Ogura, Yuichiro [2 ]
Naito, Akira [1 ]
机构
[1] Wakamoto Pharmaceut Corp Ltd, Sagami Res Labs, Oi, Kanagawa 2580018, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678601, Japan
关键词
corticosteroid(s); pharmacokinetics; injection; ophthalmic drug delivery; toxicity; DIABETIC MACULAR EDEMA; SUBTENON; ENDOPHTHALMITIS; VITRECTOMY; DELIVERY; BARRIERS; SURGERY; SAFETY; MODEL;
D O I
10.18240/ijo.2020.12.04
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To compare the differences in kinetics, distribution, and toxicity of triamcinolone acetonide (TA) between the injection methods, sub-Tenon and intravitreal injections in rabbit ocular tissues. METHODS: TA was injected into the vitreous or the sub-Tenon in rabbits. For pharmacokinetic study, rabbits were sacrificed periodically and then TA in blood and ocular tissues (retina/choroids, vitreous, and aqueous humor) were measured over 91d. For toxicological study, clinical signs, slit-lamp microscopic examination, ophthalmological test were performed. The eyeballs and surrounding tissues were collected and fixed with glutaraldehyde-formalin solution, and then paraffin embedded for histological investigation. RESULTS: Higher levels of TA were distributed in the intraocular tissues when injected into the vitreous compared to the sub-Tenon. Conversely, TA level was remarkably lower in the rabbits which received intravitreal TA injections than those treated with sub-Tenon injection throughout the study period in plasma. Optical discharge probably caused by systemic circulation of TA was observed by receiving sub-Tenon TA injection. Meanwhile, technic-associated toxicological ocular symptoms and findings were more frequently observed in intravitreal injection than in sub-Tenon injection. CONCLUSION: There are significant differences in kinetics and distribution of TA in vitreous body, aqueous humor and plasma, between the two injection methods. Although further study is needed to explain the species difference between human and rabbit, it is assumed that the difference in the frequency of intraocular pressure elevation and cataract formation by TA between the two injection methods are directly related to the TA concentrations in aqueous humor and vitreous body in each injection methods. Systemic toxicity and technic-associated toxicity are also closely related to kinetics of TA in plasma and each injection method itself, respectively.
引用
收藏
页码:1864 / 1871
页数:8
相关论文
共 50 条
  • [31] Effect of intravitreal or sub-tenon triamcinolone acetonide injection at completion of vitrectomy on peripheral retinochoroidal thickness in eyes with proliferative diabetic retinopathy
    Yoshito Fujiwara
    Takeshi Iwase
    Kentaro Yamamoto
    Yoshitaka Ueno
    Eimei Ra
    Hiroko Terasaki
    Scientific Reports, 9
  • [32] Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide
    Kuley, Brandon
    Storey, Philip P.
    Wibbelsman, Turner D.
    Pancholy, Maitri
    Zhang, Qiang
    Sharpe, James
    Bello, Nicholas
    Obeid, Anthony
    Regillo, Carl
    Kaiser, Richard S.
    Chiang, Allen
    Fineman, Mitchell S.
    Vander, James F.
    Gupta, Omesh P.
    Spirn, Marc J.
    Dunn, James P.
    Mehta, Sonia
    Park, Carl H.
    Maguire, Joseph I.
    Garg, Sunir
    CURRENT EYE RESEARCH, 2021, 46 (06) : 824 - 830
  • [33] Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema
    Jeon, Seung Hee
    Kim, Minhee
    Roh, Young-Jung
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [34] Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema
    Seung Hee Jeon
    Minhee Kim
    Young-Jung Roh
    BMC Ophthalmology, 24
  • [35] Sub-Tenon Triamcinolone Acetonide Injection in the Acute Treatment of Handheld Laser-Induced Maculopathy
    Yildirim, Nilgun
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2022, 52 (04): : 281 - 285
  • [36] Sub-tenon's triamcinolone acetonide for chronic diabetic macular edema
    Mason, JO
    Feist, RM
    Roberts, B
    Emond, TL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U201 - U201
  • [37] Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes
    Yi, N. Y.
    Davis, J. L.
    Salmon, J. H.
    Gilger, B. C.
    VETERINARY OPHTHALMOLOGY, 2008, 11 : 15 - 19
  • [38] Intravitreal versus Sub-Tenon Posterior Triamcinolone Injection in Bilateral Diffuse Diabetic Macular Edema
    Yalcinbayir, Ozgur
    Gelisken, Oner
    Kaderli, Berkant
    Avci, Remzi
    OPHTHALMOLOGICA, 2011, 225 (04) : 222 - 227
  • [39] EFFICACY AND SAFETY OF INTRAVITREAL BEVACIZUMAB COMPARED WITH INTRAVITREAL AND POSTERIOR SUB-TENON TRIAMCINOLONE ACETONIDE FOR TREATMENT OF UVEITIC CYSTOID MACULAR EDEMA
    Bae, Jeong Hun
    Lee, Christopher Seungkyu
    Lee, Sung Chul
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (01): : 111 - 118
  • [40] Safety and Effectiveness of Intravitreal Brolucizumab Injection in Combination With Sub-Tenon's Capsule Triamcinolone Acetonide Injection for Polypoidal Choroidal Vasculopathy During the Loading Phase
    Yoshikawa, Yuji
    Sakaki, Yu
    Shinoda, Kei
    Kataoka, Keiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)